Background: Short stature (SS) is a common growth disorder with multiple aetiologies. Variants in the MMP13 gene can result in varying degrees of SS, typically accompanied by pronounced skeletal abnormalities. This study aimed to investigate the genetic basis of SS in a family lacking significant imaging abnormalities and elucidate the underlying pathogenic mechanism.
Methods: Trio whole-exome sequencing was performed in a Chinese pedigree with SS to identify pathogenic variants, followed by Sanger sequencing validation. Patient-derived induced pluripotent stem cell model and CRISPR/Cas9-generated Mmp13R459fs homologous mutant mouse model were established to verify the pathogenicity of the variant. Western blotting, immunofluorescence staining, co-immunoprecipitation coupled with mass spectrometry (Co-IP/MS), histological staining and transmission electron microscopy were used to evaluate the effects of the variant on MMP13 protein function and chondrocyte development.
Results: A heterozygous frameshift variant, NM_002427.4:c.1372del(p.Arg458Valfs*31), was identified in the MMP13 gene. Mmp13R459fs mutant mice recapitulated the SS phenotype in patients, with growth plate abnormalities that were present only during the growth phase and resolved earlier than those in Mmp13 knockout mice. Co-IP/MS in HEK293T cells revealed significantly increased HSPA5 expression in the mutant, and enhanced interaction between MMP13 mutant and HSPA5 was confirmed, leading to their retention within the endoplasmic reticulum (ER). In patient-derived chondrocytes, misfolded MMP13 protein upregulated HSPA5 expression, induced significant ER dilation, activated unfolded protein response and increased chondrocyte apoptosis, ultimately contributing to MMP13-related SS.
Conclusion: This study for the first time reports the MMP13 c.1372del (p.Arg458Valfs*31) variant causes autosomal dominant SS without obvious skeletal abnormalities. The variant is associated with defective MMP13 protein secretion and ER stress. These findings expand the mutational spectrum and genotype‒phenotype correlations of the MMP13 gene, providing a novel pathogenic mechanism of SS that is important for the precise diagnosis and treatment.
Key points:
| [1] |
Andrade AC, Jee YH, Nilsson O. New genetic diagnoses of short stature provide insights into local regulation of childhood growth. Horm Res Paediatr. 2017; 88(1): 22-37.
|
| [2] |
Argente J, Pérez-Jurado LA. Genetic causes of proportionate short stature. Best Pract Res Clin Endocrinol Metab. 2018; 32(4): 499-522.
|
| [3] |
Gardner M, Boshart ML, Yeguez CE, et al. Coming up short: risks of bias in assessing psychological outcomes in growth hormone therapy for short stature. J Clin Endocrinol Metab. 2016; 101(1): 23-30.
|
| [4] |
Fan X, Zhao S, Yu C, et al. Exome sequencing reveals genetic architecture in patients with isolated or syndromic short stature. J Genet Genomics. 2021; 48(5): 396-402.
|
| [5] |
Baron J, Sävendahl L, De Luca F, et al. Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol. 2015; 11(12): 735-746.
|
| [6] |
Barat-Houari M, Sarrabay G, Gatinois V, et al. Mutation update for COL2A1 gene variants associated with type II collagenopathies. Hum Mutat. 2016; 37(1): 7-15.
|
| [7] |
Smith MM, Melrose J. COMP is a biomarker of cartilage destruction, extracellular matrix and vascular remodeling and tissue repair. Int J Mol Sci. 2025; 26(18): 9182.
|
| [8] |
Dennis EP, Watson RN, McPate F, et al. Curcumin reduces pathological endoplasmic reticulum stress through increasing proteolysis of mutant matrilin-3. Int J Mol Sci. 2023; 24(2): 1496.
|
| [9] |
Diaz Escagedo P, Fiscaletti M, Olivier P, et al. Rickets manifestations in a child with metaphyseal anadysplasia, report of a spontaneously resolving case. BMC Pediatr. 2021; 21(1): 248.
|
| [10] |
Song C, Li N, Hu X, et al. A de novo variant in MMP13 identified in a patient with dominant metaphyseal anadysplasia. Eur J Med Genet. 2019; 62(11):103575.
|
| [11] |
Bonafé L, Liang J, Gorna MW, et al. MMP13 mutations are the cause of recessive metaphyseal dysplasia, Spahr type. Am J Med GenetA. 2014; 164A(5): 1175-1179.
|
| [12] |
Pendás AM, Matilla T, Estivill X, et al. The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics. 1995; 26(3): 615-618.
|
| [13] |
Ji Z, Ren X, Jin J, et al. Injectable hydrogel encapsulating siMMP13 with anti-ROS and anti-apoptotic functions for osteoarthritis treatment. J Nanobiotechnol. 2024; 22(1): 466.
|
| [14] |
Saiganesh S, Saathvika R, Udhaya V, Arumugam B, Vishal M, Selvamurugan N. Matrix metalloproteinase-13: a special focus on its regulation by signaling cascades and microRNAs in bone. Int J Biol Macromol. 2018; 109: 338-349.
|
| [15] |
Lausch E, Keppler R, Hilbert K, et al. Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia. Am J Hum Genet. 2009; 85(2): 168-178.
|
| [16] |
Bassiouni W, Ali MAM, Schulz R. Multifunctional intracellular matrix metalloproteinases: implications in disease. FEBS J. 2021; 288(24): 7162-7182.
|
| [17] |
Inada M, Wang Y, Byrne MH, et al. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A. 2004; 101(49): 17192-17197.
|
| [18] |
Duncan HF, Kobayashi Y, Yamauchi Y, et al. The reparative function of MMP13 in tertiary reactionary dentinogenesis after tooth injury. Int J Mol Sci. 2024; 25(2): 875.
|
| [19] |
Fan M, Tong P, Yan L, et al. Detrimental alteration of mesenchymal stem cells by an articular inflammatory microenvironment results in deterioration of osteoarthritis. BMC Med. 2023; 21(1): 215.
|
| [20] |
Zheng Z, Shang X, Sun K, et al. P21 resists ferroptosis in osteoarthritic chondrocytes by regulating GPX4 protein stability. Free Radic Biol Med. 2024; 212: 336-348.
|
| [21] |
Jian M, Sun X, Cheng G, et al. Discovery of phenolic matrix metalloproteinase inhibitors by peptide microarray for osteosarcoma treatment. J Nat Prod. 2022; 85(10): 2424-2432.
|
| [22] |
Stickens D, Behonick DJ, Ortega N, et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development. 2004; 131(23): 5883-5895.
|
| [23] |
Kennedy AM, Inada M, Krane SM, et al. MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMDMO). J Clin Invest. 2005; 115(10): 2832-2842.
|
| [24] |
Qiu Y, Wang H, Fan M, et al. Impaired AIF-CHCHD4 interaction and mitochondrial calcium overload contribute to auditory neuropathy spectrum disorder in patient-iPSC-derived neurons with AIFM1 variant. Cell Death Dis. 2023; 14(6): 375.
|
| [25] |
Gao L, Wang F, Wang Y, et al. A protocol for the generation of patient-specific iPSC lines from peripheral blood mononuclear cells. STAR Protoc. 2022; 3(3):101530.
|
| [26] |
Cavarzere P, Pietrobelli A, Gandini A, et al. Role of genetic investigation in the diagnosis of short stature in a cohort of Italian children. J Endocrinol Invest. 2024; 47(5): 1237-1250.
|
| [27] |
Ritter AL, Gold J, Hayashi H, et al. Expanding the phenotypic spectrum of ARCN1-related syndrome. Genet Med. 2022; 24(6): 1227-1237.
|
| [28] |
Pretemer Y, Kawai S, Nagata S, et al. Differentiation of hypertrophic chondrocytes from human iPSCs for the in vitro modeling of chondrodysplasias. Stem Cell Reports. 2021; 16(3): 610-625.
|
| [29] |
Zhang T, Li J, Yang M, et al. CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. Oncogene. 2022; 41(40): 4524-4536.
|
| [30] |
Zielke S, Kardo S, Zein L, et al. ATF4 links ER stress with reticulophagy in glioblastoma cells. Autophagy. 2021; 17(9): 2432-2448.
|
| [31] |
Hecht JT, Veerisetty AC, Hossain MG, et al. Joint degeneration in a mouse model of pseudoachondroplasia: ER stress, inflammation, and block of autophagy. Int J Mol Sci. 2021; 22(17): 9239.
|
| [32] |
Amodei L, Ruggieri AG, Potenza F, et al. Sil1-deficient fibroblasts generate an aberrant extracellular matrix leading to tendon disorganisation in Marinesco-Sjögren syndrome. J Transl Med. 2024; 22(1): 787.
|
| [33] |
Tsang KY, Chan D, Cheslett D, et al. Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol. 2007; 5(3):e44.
|
| [34] |
Bateman JF, Boot-Handford RP, Lamandé SR. Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat Rev Genet. 2009; 10(3): 173-183.
|
| [35] |
Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020; 21(8): 421-438.
|
| [36] |
Xu F, Du W, Zou Q, et al. COPII mitigates ER stress by promoting formation of ER whorls. Cell Res. 2021; 31(2): 141-156.
|
| [37] |
Yang X, Zhou T, Wang X, et al. Loss of DDRGK1 impairs IRE1α UFMylation in spondyloepiphyseal dysplasia. Int J Biol Sci. 2023; 19(15): 4709-4725.
|
| [38] |
Glab JA, Doerflinger M, Nedeva C, et al. DR5 and caspase-8 are dispensable in ER stress-induced apoptosis. Cell Death Differ. 2017; 24(5): 944-950.
|
| [39] |
Ren J, Bi Y, Sowers JR, et al. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases. Nat Rev Cardiol. 2021; 18(7): 499-521.
|
| [40] |
Li D, Weber DR, Deardorff MA, et al. Exome sequencing reveals a nonsense mutation in MMP13 as a new cause of autosomal recessive metaphyseal anadysplasia. Eur J Hum Genet. 2015; 23(2): 264-266.
|
| [41] |
Bernales S, Papa FR, Walter P. Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol. 2006; 22: 487-508.
|
| [42] |
Hetz C, Axten JM, Patterson JB. Pharmacological targeting of the unfolded protein response for disease intervention. Nat Chem Biol. 2019; 15(11): 1129.
|
| [43] |
Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007; 8(7): 519-529.
|
RIGHTS & PERMISSIONS
2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
PDF
(15503KB)
